Profile
Hiroyuki Ueno is currently a Director at Alphanavi Pharma KK and an Executive Manager at Kyoto University Innovation Capital Co., Ltd.
He previously worked as an Outside Director at Chordia Therapeutics, Inc.
Hiroyuki Ueno active positions
| Companies | Position | Start |
|---|---|---|
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 01/10/2020 |
Alphanavi Pharma KK
 Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Director/Board Member | - |
Former positions of Hiroyuki Ueno
| Companies | Position | End |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
Alphanavi Pharma KK
Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Health Technology |
- Stock Market
- Insiders
- Hiroyuki Ueno
